Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

Nanoparticle-Based Delivery Systems for Vaccines
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 136
An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy
Zahra Yousefi, Hamid Aria, Farhoodeh Ghaedrahmati, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 102
Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review
Khatereh Asadi, Ahmad Gholami
International Journal of Biological Macromolecules (2021) Vol. 182, pp. 648-658
Open Access | Times Cited: 78
Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis
Tynisha S. Rafael, Jossie Rotman, Oscar R. Brouwer, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 1101-1101
Open Access | Times Cited: 19
RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer
Pola Olczak, Ken Matsui, Margaret Wong, et al.
Journal of Virology (2022) Vol. 96, Iss. 13
Open Access | Times Cited: 16
New Perspectives in Therapeutic Vaccines for HPV: A Critical Review
Bárbara Gardella, Andrea Gritti, Ehsan Soleymaninejadian, et al.
Medicina (2022) Vol. 58, Iss. 7, pp. 860-860
Open Access | Times Cited: 15
Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas
D. Tsakogiannis, Marios Nikolaidis, Flora Zagouri, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 141-141
Open Access | Times Cited: 15
Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development
Melinda Ahmels, Filipe Colaço Mariz, Ilona Braspenning‐Wesch, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP
Sarah Valencia, Athina Zacharia, Alexander Marin, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 8, pp. 2748-2761
Open Access | Times Cited: 16
Human Papillomavirus Vaccines
John T. Schiller, Lauri E. Markowitz, Aimée R. Kreimer, et al.
Elsevier eBooks (2023), pp. 484-513.e11
Closed Access | Times Cited: 5
The use of nanoparticles in the treatment of infectious diseases and cancer, dental applications and tissue regeneration: a review
Ali Sobhani‐Nasab, Hamid Reza Banafshe, Amir Atapour, et al.
Frontiers in Medical Technology (2024) Vol. 5
Open Access | Times Cited: 1
Knowledge on Human Papillomavirus Infections, Cancer Biology, Immune Interactions, Vaccination Coverage and Common Treatments: A Comprehensive Review
Nika Nikmanesh, SeyedehZahra Hosseini, Fatemehsadat Mirbagheri, et al.
Viral Immunology (2024) Vol. 37, Iss. 5, pp. 221-239
Closed Access | Times Cited: 1
Expression of Chimeric HPV-HIV Protein L1P18 in Pichia pastoris; Purification and Characterization of the Virus-like Particles
Yoshiki Eto, Narcı́s Saubi, Pau Ferrer, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1967-1967
Open Access | Times Cited: 9
Dissection of Capsid Protein HPV 52 to Rationalize Vaccine Designs Using Computational Approaches Immunoinformatics and Molecular Docking
Moh Egy Rahman Firdaus, Apon Zainal Mustopa, Lita Triratna, et al.
Asian Pacific Journal of Cancer Prevention (2022) Vol. 23, Iss. 7, pp. 2243-2253
Open Access | Times Cited: 6
Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope
Maryam Mashhadi Abolghasem Shirazi, Seyed Mehdi Sadat, Setareh Haghighat, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Immunotherapeutic approaches for HPV-caused cervical cancer
Seyed Amirreza Fatemi, Nadia Seifi, Shiva Rasekh, et al.
Advances in protein chemistry and structural biology (2022), pp. 51-90
Closed Access | Times Cited: 4
Novel Vaccine Strategies and Factors to Consider in Addressing Health Disparities of HPV Infection and Cervical Cancer Development among Native American Women
Crystal G. Morales, Nicole R. Jimenez, Melissa M. Herbst‐Kralovetz, et al.
Medical Sciences (2022) Vol. 10, Iss. 3, pp. 52-52
Open Access | Times Cited: 4
Genetic variability in minor capsid protein (L2 gene) of human papillomavirus type 16 among Indian women
Arati Mane, Sanket Limaye, Linata Patil, et al.
Medical Microbiology and Immunology (2022) Vol. 211, Iss. 2-3, pp. 153-160
Open Access | Times Cited: 3
Vaccination with a Human Papillomavirus L2 Multimer Provides Broad Protection against 17 Human Papillomavirus Types in the Mouse Cervicovaginal Challenge Model
Zhenwei Han, Shen Wang, Ting Mu, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 689-689
Open Access
Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2
Filipe Colaço Mariz, Kerstin Putzker, Peter Sehr, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Human Papillomavirus Type 16 L2 Gene Sequence Variation Analysis in Indonesian Cervical Cancer Specimens
Syandrez Prima Putra, Andani Eka Putra, Indwiani Astuti, et al.
Asian Pacific Journal of Cancer Prevention (2022) Vol. 23, Iss. 6, pp. 2009-2016
Open Access | Times Cited: 1
A Glance on Nanovaccine: A Potential Approach for Disease Prevention
Akash Garg, Rutvi Agrawal, Himansu Chopra, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 11, pp. 1406-1418
Closed Access
Human Papilloma-Virus Associated Carcinomas and Warts
Anne Schuind
(2021)
Closed Access
Human Papillomavirus Type 16 L2 Gene Sequence Variation Analysis in Indonesian Cervical Cancer Specimens
Syandrez Prima Putra, Andani Eka Putra, Indwiani Astuti, et al.
Research Square (Research Square) (2021)
Open Access
Immunoinformatics Approach for Designing an HPV Epitope-Based Vaccine Candidate Harboring Built-in Adjuvants
Maryam Mashhadi Abolghasem Shirazi, Arash Arashkia, Setareh Haghighat, et al.
Vaccine Research (2021) Vol. 8, Iss. 2, pp. 28-38
Open Access
Page 1

Scroll to top